Colorectal LLM Wiki

Browse
Home / Procedures / Total Mesorectal Excision (TME) & Sphincter-Sparing Resection
Procedure created 2026-08-19 · updated 2026-08-27
colorectalrectal-cancerTMELARtaTMEcoloanal-anastomosis

Total Mesorectal Excision (TME) & Sphincter-Sparing Resection

Covers the core oncologic rectal resection (low anterior resection with TME) and the technique variants used to preserve the sphincter for progressively lower tumors: coloanal anastomosis with mucosectomy/intersphincteric dissection, and transanal TME (taTME). See Abdominoperineal Resection (APR) for the alternative when sphincter preservation isn't possible, and Local Excision of Rectal Neoplasms for the non-radical alternative for very early lesions. Content below is from a textbook reference chapter (Sabiston Ch52 - Rectal Cancer Surgery), not primary literature.

Why TME

An oncologically radical resection of the rectum must be performed along a precise anatomic plane, en bloc with its mesorectum (where the rectal lymphatics and lymph nodes are located). The mesorectum is enveloped by the mesorectal fascia, whose integrity must be kept intact during dissection — shown to be crucial for reducing local recurrence risk. This — removing the rectum and the mesorectum along this precise plane — is what "total mesorectal excision" (TME) means. See Rectal Cancer for the history of how TME (Heald), the circumferential resection margin concept (Quirke), and preoperative chemoradiation together drove the major improvement in modern rectal cancer outcomes.

Background, per ASCRS Ch29 - Proctectomy for Rectal Cancer: as recently as four decades ago, pelvic recurrence following resection of locally advanced rectal cancer was estimated at ~30%, with over 80% of those recurrences becoming clinically evident within the first 2 years after surgery. During that same period, overall recurrence was ~40% for generalist surgeons vs. 10–20% for specialist surgeons — early evidence that operative technique itself profoundly affects prognosis, independent of tumor biology. Bill Heald demonstrated that attention to anatomic detail during proctectomy was associated with good outcomes, emphasizing that appropriate mesorectal resection — extirpating the contents of the embryologic fascia propria envelope (perirectal fat, blood vessels, lymph nodes/channels) along embryologic fusion planes — was key to minimizing pelvic recurrence. Around the same time, pathologist Phil Quirke described optimal gross/histologic evaluation of proctectomy specimens — measurement of the circumferential resection margin (CRM) and grading of mesorectal-excision completeness — establishing that the most common cause of pelvic failure was radial (CRM) tumor spread, not axial extent. Rectal cancer with a CRM <1mm (a positive margin) has a

50% local recurrence rate, vs. 17% with a margin >1mm. Anna Martling and colleagues subsequently showed that adding radiotherapy to TME further reduces recurrence compared with TME alone.

Anatomy of the rectum and mesorectum

A nerve-sparing TME is facilitated by a working knowledge of the embryologic origins of the pelvic structures. The hindgut develops into the rectum and upper anal canal; the urogenital septum forms between the cloaca and allantois to form the perineal body, separating the urogenital structures from the terminal GI tract — these embryologic planes are the basis for the TME dissection planes.

  • Blood supply: the rectum's blood supply is segmental in concept, though in practice a rich interconnected submucosal vascular plexus makes the rectum difficult to truly devascularize during proctectomy. The upper rectum receives blood from the inferior mesenteric artery (IMA), which splits into the left colic artery and the superior rectal (hemorrhoidal) artery 2–3cm from its aortic origin. There is no universally agreed nomenclature for exactly where the IMA "becomes" the superior rectal artery — this ambiguity matters because it makes "high" vs. "low" ligation mean different things to different surgeons. The middle rectal artery supplies the mid rectum and, despite being described in all anatomic/surgical texts, is only identifiable at surgery in 10–20% of patients. The inferior rectal artery supplies the lowest third of the rectum, arising from the terminal branches of the internal iliac artery. Venous drainage mirrors arterial supply: the upper rectum drains via the inferior mesenteric vein into the portal circulation; the remainder drains via the iliac veins into the systemic circulation.
  • The mesorectum and the "holy plane": the mesorectum contains lymph nodes, blood supply, perirectal fat, and connective tissue, surrounded by an envelope called the fascia propria of the rectum. Along the "sacral hollow" are the iliac vessels, hypogastric nerves, and presacral veins, covered anteriorly by a thin lining called the presacral fascia. Between the presacral fascia and the fascia propria of the rectum is an avascular, loose areolar plane — the plane of dissection for an oncologic proctectomy in tumors that don't breach the mesorectal fascia — what Heald calls the "holy plane." The degree of precision with which the surgeon dissects in this plane determines whether the patient gets a complete oncologic resection with an intact mesorectum on pathology review. Violating the fascia propria can leave retained mesorectum after extirpation (increasing recurrence risk); violating the presacral fascia can cause nerve injury (leading to sexual/bladder dysfunction) and bleeding from the presacral venous plexus — potentially severe, since pelvic-plexus venous pressure can be comparable to or higher than inferior vena cava pressure.
  • Denonvilliers' fascia and Waldeyer's fascia: anteriorly, at about the middle third of the rectum, the rectum is separated from the prostate/seminal vesicles (or vagina) and the autonomic nerve plexus by a thin septum, Denonvilliers' fascia. Staying outside/posterior to this fascia during dissection decreases the likelihood of injuring the periprostatic/perivaginal autonomic nerves; there is little to no mesorectal tissue between the rectum and the prostate/vagina anteriorly at the lowest third of the rectum. Posteriorly, at approximately the level of S4, the presacral fascia and the fascia propria connect and thicken to form Waldeyer's fascia, which must be divided during proctectomy to fully mobilize the rectum posteriorly to the levator complex.
  • Autonomic innervation: sympathetic innervation of the urogenital organs originates from the superior hypogastric plexus, and parasympathetic innervation from the pelvic splanchnic nerves. The superior hypogastric plexus travels caudally from about the level of the IMA toward the aortic bifurcation; at the sacral promontory it splits into the left and right hypogastric nerves, which travel along the pelvic sidewall (lateral and posterior to the pelvic side wall) and join the pelvic splanchnic nerves (the nervi erigentes) — together forming the inferior hypogastric plexus. The inferior hypogastric plexus can be tethered to the mesorectum inferolaterally and must be carefully separated during dissection. Injury to these nerves causes urogenital abnormalities: urinary retention and retrograde ejaculation with sympathetic (hypogastric nerve) injury, and loss of erection with parasympathetic (pelvic splanchnic nerve) injury. See General Postoperative Complications for this wiki's existing quantified erectile/ejaculatory dysfunction rates after proctectomy — this anatomy underlies that data.

Priorities in proctectomy

Per ASCRS Ch29 - Proctectomy for Rectal Cancer: regardless of the expanding menu of neoadjuvant regimens and surgical technologies available, the priorities of rectal cancer surgery stay constant: (1) appropriate mesorectal excision using sharp dissection to provide the optimal oncologic resection; (2) nerve-sparing proctectomy; (3) continent reconstruction whenever possible, but not at the expense of a positive resection margin or poor functional outcome.

Preoperative preparation

Per ASCRS Ch29 - Proctectomy for Rectal Cancer: patients undergoing elective proctectomy typically receive cathartic mechanical bowel preparation (MBP) plus oral antibiotics (OA; neomycin/erythromycin or neomycin/metronidazole) — registry data now support combined MBP+OA over MBP alone or no preparation: a VASQIP study of 9940 colectomy patients found MBP+OA halved the surgical-site-infection rate compared to MBP alone or no preparation; an NSQIP series of 4999 patients found MBP+OA associated with significantly lower SSI, anastomotic leak, and readmission compared to no preparation, MBP alone, or OA alone; a further NSQIP study of 8442 patients found combined MBP+OA independently associated with reduced anastomotic leak and postoperative ileus; and Margolin et al.'s series of 27,804 patients undergoing elective colorectal resection recapitulated these SSI/deep-organ-space-infection/leak benefits with no increased C. difficile risk. The current ASCRS Clinical Practice Guidelines Committee recommends combined MBP+OA before elective colon and rectal surgery. Rectal enemas are not an adequate substitute for MBP+OA — evidence supporting enemas alone is from small, poorly designed studies — and enemas alone will not adequately clear stool between a diverting loop stoma and the anastomosis if restorative proctectomy with proximal diversion is planned (residual stool can slowly extrude from a leak site if one occurs). Potential stoma sites should be marked preoperatively, with patient education on stoma care by an enterostomal therapist/certified wound ostomy continence nurse.

Low anterior resection (LAR)

After vascular division (similar to a left colectomy), the peritoneal reflection of the rectum is divided at the level of the sacral promontory, and the rectum with its proximal mesorectum is gently pulled anteriorly, entering the avascular "cotton candy" plane between the mesorectal fascia and the presacral fascia. Extra care is needed to avoid injuring the hypogastric nerves, which must be visualized. Anteriorly, the cul-de-sac is divided, and the rectum is dissected away from the seminal vesicles (men) or vagina (women). For cancers in the upper rectum, the rectum and mesorectum are divided 5 cm below the cancer — a subtotal mesorectal excision. For cancers in the distal two-thirds of the rectum, dissection continues more distally, off the prostate along the fascia of Denonvilliers; posteriorly, dissection continues to the level of the levator muscles en bloc with the entire mesorectum, keeping the mesorectal fascia intact. The most distal rectum is "naked" (not surrounded by mesorectum, which ends a few cm proximally) — at this level the rectum can be divided with a stapler (several reloads may be needed to complete the transection in the distal pelvis in laparoscopy). This complete operation — removing the rectum en bloc with its entire mesorectum — is what makes it a TME. The integrity of the visceral fascia is a crucial point defining TME quality and is directly related to the disease-free-survival (DFS) interval; proper excision along the anatomic plane is essential to obtain free circumferential radial margins, reducing local recurrence to below 5%, and also significantly decreasing urinary and sexual dysfunction (retrograde ejaculation, impotence). Quantified per General Postoperative Complications (ASCRS Ch8): one prospective 169-patient study found 71% postoperative erectile dysfunction (vs. 24% preoperative) and 78% postoperative ejaculatory dysfunction (vs. 32%) after proctectomy for rectal cancer (p<0.001), with T3/T4 stage and low rectal tumors as independent risk factors; sildenafil significantly improved erectile function vs. placebo (80% vs. 17%) in a small RCT.

Laparoscopic TME shows similar results to open surgery for quality of resection, circumferential margin clearance, and recurrence rate. DFS for stages II–III is about 75% regardless of surgical approach. The colorectal anastomosis is typically made with a circular stapler inserted transanally; the pelvis is filled with water and air insufflated through the anastomosis (proximal colon occluded) to check for leaks. A loop diverting ileostomy is commonly used to protect the distal colorectal anastomosis from stool passage until healing is complete, especially in patients who received preoperative chemoradiation — usually maintained at least 8 weeks, closed only after confirming perfect healing with a gastrografin enema or endoscopy.

Open LAR technique detail

Per ASCRS Ch29 - Proctectomy for Rectal Cancer: patient positioned in low lithotomy or split-leg (lithotomy needed if handsewn coloanal anastomosis is contemplated; split-leg preferred for stapled anastomosis). DRE localizes the tumor and assesses anal compliance/stapler-size selection; proctoscopy (rigid or flexible video with CO₂ insufflation, which limits bowel distention) helps localize a nonpalpable tumor and should be used liberally throughout the dissection — palpation through the rectal wall can be inaccurate, especially for small tumors or after neoadjuvant therapy. A midline incision accommodates temporary stoma sites and can be extended cephalad for splenic flexure mobilization. Sigmoid colon is mobilized lateral-to-medial along the white line of Toldt; the left ureter and gonadal vessels are identified and protected (a vessel loop around the ureter can help confirm its location/course throughout the case). Full splenic flexure mobilization (entering the lesser sac, dividing the omentum, freeing attachments to the spleen/Gerota's fascia) is performed to allow maximal reach.

The IMV is identified at the ligament of Treitz and given a high ligation, sometimes supplying up to an additional 15cm of left-colon reach into the pelvis. The surgeon then decides whether to divide the IMA at the aorta, or to divide the superior rectal artery at its origin (~2cm from the aorta) while preserving the left colic artery — a decision based on conduit mobility and blood supply quality, with no demonstrated oncologic-outcome difference between the two techniques. Dividing the IMA at the aorta gives greater mobility, but the conduit's arterial supply then depends solely on the left branch of the middle colic artery (which must be meticulously preserved during splenic-flexure mobilization and IMV division); dividing the superior rectal artery at its origin preserves dual conduit blood supply (from both the middle colic artery and, via the left colic artery, the IMA) at the cost of some conduit mobility. For distal rectal tumors, division of the IMA at the aorta is typically necessary for adequate reach.

Rectal dissection proceeds in the "holy plane" between the presacral fascia and fascia propria of the rectum, with the left and right hypogastric nerves identified and kept out of harm's way; dissection is entirely sharp (electrocautery or scissors). Posteriorly, loose areolar tissue coalesces into Waldeyer's fascia, which is divided until the superior levators are encountered; the lateral stalks are taken in the same fashion down to the pelvic floor (a bipolar vessel-sealing device can minimize bleeding from the middle rectal vessels here, weighed against device cost). Anteriorly, the plane between the rectum and the seminal vesicles/prostate or vagina must be carefully dissected to ensure complete tumor removal while avoiding injury to the prostate/vagina and the nerves adjacent to Denonvilliers' fascia. For mid/distal rectal cancers, the rectum is freed anteriorly down to the pelvic floor so a stapler can transect the rectum flush with the levators, with tumor location reconfirmed by flexible proctoscopy immediately before transection.

For proximal rectal cancer, there's no oncologic benefit to removing mesorectum more than 5cm distal to the tumor — a "tumor-specific mesorectal excision" may be performed instead of a full TME, preserving the distal rectum (associated with better functional outcomes and lower anastomotic leak rates than removing nearly the entire rectum). It's critical to divide the mesorectum perpendicular to the rectum's longitudinal axis at the appropriate level, avoiding "coning in" on the mesorectum. The term "TME" is used loosely for this technique too, which causes some confusion — it's better understood as a technique for dissecting in the avascular plane surrounding the mesorectum (applicable whether a full or tumor-specific excision is performed) than as a specific operation; "proctectomy" is the more accurate general term for the operation itself.

For very distal cancers not invading the anal sphincter or pelvic floor, the rectum may be divided via a transanal approach (before, after, or simultaneously with abdominal mobilization) — a self-retaining retractor/operating anoscope provides exposure, the rectum is divided in full-thickness fashion via electrocautery at an appropriate distance from the tumor, and dissection proceeds proximally to connect with the abdominally mobilized plane (often facilitated by the abdominal operator placing a hand in the pelvis to guide the perineal dissection by palpation).

Once the specimen is off the table, the surgeon should observe an intact, glistening fascia propria over the mesorectum with no noticeable divots — the non-peritonealized radial margin should be marked with ink (optimally by the surgeon) before sending the specimen to pathology, to allow CRM measurement. Low colorectal and coloanal anastomoses should typically be protected with a proximal diverting loop ileostomy (~25–30cm proximal to the ileocecal valve); in rare cases with a redundant proximal colon, a diverting loop transverse colostomy may be preferable (lower dehydration risk than ileostomy).

Anastomosis techniques and low-pelvic reservoir options

Per ASCRS Ch29 - Proctectomy for Rectal Cancer — see Anastomotic Construction for this wiki's existing general outcome-comparison data (J-pouch vs. straight vs. side-to-end) on these same reconstruction options; the technique specifics below complement that page's outcome data:

  • Straight stapled anastomosis: the most common configuration — an end-to-end stapler with the anvil placed via a purse-string suture in the distal end of the left colon conduit, passed transanally, with the pin brought out as close as possible to the rectal transection staple line to avoid an ischemic tissue ridge adjacent to the new anastomosis. Following construction, endoscopic inspection and a pneumatic leak test should be performed (ideally with flexible video endoscopy and CO₂ insufflation): the pelvis is filled with saline, the proximal colon occluded, and gas instilled via the colonoscope — bubbling indicates a defect requiring repair; mucosa should be pink/healthy both proximally and distally, and any pulsatile hemorrhage addressed (typically with endoscopic clips).
  • Handsewn coloanal anastomosis: used when an ultralow anastomosis is required, or as a salvage technique after a stapler misfire. Typically single-layer absorbable suture, interrupted and/or running, with initial four-quadrant suture placement to facilitate exposure/orientation.
  • Colonic J-pouch anastomosis: the distal conduit is folded into a "J" configuration ~7cm in length; the antimesenteric bowel surface at the apex of the "J" is opened so a 75–80mm linear stapler can be passed into each limb and fired, creating a ~7–8cm common channel. If a double-stapled anastomosis is planned, the circular-stapler anvil is sewn into the pouch apex and an end-to-end anastomosis performed as described above; if handsewn, the apex is opened and delivered via the anus for a handsewn anastomosis. J-pouch reconstruction requires the folded conduit to both reach the anus and fit within the pelvis — patients with visceral obesity and a narrow pelvis are often not suitable.
  • End-to-side ("Baker") anastomosis: an alternative when a colonic J-pouch is too bulky for the pelvis (particularly in the narrow male pelvis or in obese patients) — a variant end-to-side configuration with a ~3cm side segment, found in several studies/reviews to have function similar to a colonic J-pouch.
  • Transverse coloplasty: creates a neorectum without the double bowel-and-mesentery thickness required for a J-pouch — an 8–10cm incision is made along the longitudinal axis of the colon, ending ~5cm proximal to the distal end, then closed transversely to create a small pouch. Used more frequently in the past; recent use has declined, as several studies have shown a higher likelihood of leak and no functional difference compared with other neorectal configurations.

Laparoscopic and robotic LAR

Per ASCRS Ch29 - Proctectomy for Rectal Cancer: laparoscopic LAR uses low lithotomy or split-leg positioning with extreme Trendelenburg and airplaning capability; diagnostic laparoscopy first confirms absence of peritoneal carcinomatosis/liver metastasis; a typical port setup uses a supraumbilical 12mm camera trocar, 5mm left-iliac-fossa and right-upper-quadrant trocars, and a 12mm right-iliac-fossa trocar (10mm 30° laparoscope typically preferred over 5mm for image quality and fewer camera exchanges). Technique otherwise mirrors the open approach (medial-to-lateral or lateral-to-medial IMA/sigmoid mobilization, high IMA/IMV ligation, splenic flexure mobilization, "holy plane" rectal dissection with hypogastric nerve preservation) — a 45mm or 30mm laparoscopic linear stapler is typically used for rectal transection (a 60mm stapler rarely fits the pelvis), often requiring more than one firing (minimizing the number of firings reduces crossing-staple-line leak risk).

Robotic LAR has become many surgeons' preferred minimally invasive approach, given the ergonomics, magnification, 3D visualization, and wristed instrumentation robotic platforms offer — most surgeons have moved to a single-dock technique (e.g. with the da Vinci Xi platform). A typical single-dock setup: pneumoinsufflation via a right-upper-quadrant optical trocar (which becomes the assistant port), ~30° Trendelenburg with ~8° right-side-down tilt, and four robotic ports placed along a diagonal line from the right ASIS through the umbilicus toward the left subcostal margin (the first robotic port serving as the stapling port, the last as the camera port). Dissection technique is otherwise identical to standard laparoscopy; after rectal transection the robot is undocked and the remainder of the case (specimen extraction, anastomosis) completed with standard laparoscopy. Per ASCRS Ch36 - Colorectal Cancer Minimally Invasive Surgery, robotic proctectomy can also be performed fully robotic or via a hybrid laparoscopic/robotic technique (splenic flexure mobilization and vessel ligation performed laparoscopically, with the robot docked only for rectal mobilization) — no comparative studies show one superior; the hybrid approach realizes the robot's benefit where it matters most (the narrow pelvis) while avoiding time-consuming re-docking for splenic flexure work. Disadvantages of robotic surgery: lack of haptic feedback, longer operative time, and cost. The ROLARR RCT (conversion-to-open as primary outcome) failed to demonstrate that robotic surgery reduces conversion rate vs. laparoscopy, and found no difference in short- or long-term outcomes between the approaches; robotic surgery was on average £980 more expensive than laparoscopic, even excluding acquisition/maintenance costs. Other RCTs found similar short-term, long-term, and functional outcomes between laparoscopic and robotic approaches. Docking is the most time-consuming aspect of robotic surgery, especially with multiple dockings, though recent meta-analyses show similar operating times for robotic and laparoscopic proctectomy as surgical teams gain experience.

Technical limitations of distal rectal transection, per Ch36: the fulcrum effect of operating a stapler through an iliac-fossa port; limited stapler angulation (a virtual simulation study showed staplers would need to go through the iliac bone to achieve a 90° transection angle at the levator ani level); the multiple-staple-firing requirement noted above (single-firing perpendicular transection is ideal but often not achievable). Intersecting lateral staple lines ("dog ears") after double-stapled anastomosis are considered weak structural spots prone to leak. Two described techniques to reduce dog ears: the "tennis racket" technique (anvil spike brought through the rectal stump laterally rather than centrally, eliminating one intersecting staple line) and the "reverse smile" technique (spike brought through just posterior to the linear staple line, then the stapler shaft retracted and angled anteriorly, pulling the staple line edges toward the midline posterior to the spike) — the latter can transform a double-stapled into an essentially single-stapled anastomosis. A hand-assisted device inserted at this point in the case ameliorates the fulcrum effect, stabilizes pneumoperitoneum via the hand-port seal, and allows tumor palpation for a safe distal margin, at increased cost — see the Hand-assisted laparoscopic surgery subsection below.

Trial evidence, per Ch36: the CLASICC trial found a 12% rate of involved circumferential radial margins (CRM) after laparoscopic restorative proctectomy vs. 6% in the open arm, and a 34% conversion rate — concluding suboptimal short-term outcomes did not yet justify routine laparoscopic use, though 5-year follow-up showed no OS/DFS differences. The COREAN trial showed short-term benefits (decreased blood loss, postoperative pain, length of stay) and comparable 3-year DFS for laparoscopic vs. open proctectomy after neoadjuvant chemoradiation in non-metastatic mid-low rectal cancer. These two trials corroborate, and add further named-trial detail to, this page's Oncologic outcomes section below (which already covers ACOSOG Z6051 and ALaCaRT from Ch29 — Ch36 corroborates those two trials with matching CRM/conversion detail rather than extending them).

Hand-assisted laparoscopic surgery (HALS)

Per Ch36: developed in the late 1990s to overcome laparoscopic limitations while retaining most laparoscopic benefits. Uses a hand-assist device (stable platform, circumferential wound retraction, self-sealing membrane for hand exchange/trocar placement while maintaining pneumoperitoneum) through a 4-8cm incision (sized to the surgeon's glove size) usable from the start of the case for both mesenteric mobilization/anastomosis and, if body habitus is favorable, direct hand-assisted mesorectal mobilization (a "hybrid" approach). HALAR (hand-assisted laparoscopic anterior resection) findings, summarizing 11 comparative studies: retains many pure-laparoscopic benefits; comparable complication rate and length of stay vs. straight laparoscopic approach; comparable oncologic outcomes vs. laparoscopic or open; shorter operative time and lower conversion rate than straight laparoscopy; slightly longer incision and increased inflammatory-marker levels vs. straight laparoscopic (both of unclear clinical significance). HALS allows the recommendation to avoid straight laparoscopic proctectomy for rectal cancer (per the CLASICC/ACOSOG/ALaCaRT concerns above) to be honored while still gaining most laparoscopic benefits, particularly in patients with unfavorable body habitus.

Sphincter-sparing surgery for low rectal cancers

Tumors at the ultradistal rectum (at or just above the dentate line) pose a specific challenge because of their proximity to the anal sphincter. In young, fit patients with good preoperative sphincter function, if the sphincters aren't infiltrated with cancer and don't need to be sacrificed oncologically, a coloanal anastomosis is feasible. The ultradistal rectum can't be stapled from the abdomen, so this dissection and reconstruction is done transanally.

  • Standard mucosectomy: the distal mucosa is peeled off the internal sphincter, which is spared. Ideally, 1–2 cm of mucosa above the dentate line is preserved — this portion has critical importance for rectal sensibility and postoperative functional outcomes.
  • Asymmetric mucosectomy: if the cancer is lower but small and involves only a small portion of the mucosa, mucosectomy en bloc with the underlying internal sphincter can be done on one side of the anal canal only, sparing part of the distal mucosa and sphincter on the other side.
  • Intersphincteric dissection: if the cancer involves a larger part of the anal canal, this more extensive dissection is needed — the internal sphincter (responsible for resting anal pressure) is removed circumferentially. Functional results are poor here due to loss of both sensation and resting anal pressure.

The completed coloanal anastomosis is hand-sewn with interrupted sutures between the colon and the distal rectum. See Anastomotic Construction for this wiki's general hand-sewn-vs-stapled technique discussion, plus low-pelvic reservoir options (colonic J-pouch, side-to-end anastomosis) not detailed on this page.

Transanal total mesorectal excision (taTME)

A newer technique proposed to facilitate sphincter-preserving procedures by improving detachment of the rectum and vision in the narrow pelvic space. Uses transanal platforms also used for TAMIS. The distal rectum is closed with a purse string and divided with a harmonic scalpel; the transanal port platform is positioned through the anus, and rectal dissection proceeds from the bottom upward, going from a narrow to a wider space (retropneumoperitoneum inflated through the port aids blunt, atraumatic dissection along avascular planes under clear laparoscopic vision). Detachment of the rectum is done posteriorly first, then anteriorly from the prostate plane, continuing until the cul-de-sac is entered. The procedure then continues within the abdomen with standard laparoscopic or robotic instruments once the colon has been mobilized; when the pelvis has been approached transabdominally, the distal rectum is often already fully detached and can be easily exteriorized.

taTME has been shown to be oncologically safe, with a low rate of involved circumferential margins and good quality of mesorectal excision. After the operation, all patients show a decrease in resting sphincter pressures, but squeeze pressures are unchanged, and functional results are described as acceptable.

Two-team technique and outcome data, per ASCRS Ch29 - Proctectomy for Rectal Cancer: taTME is typically performed as a two-team simultaneous approach — one team works laparoscopically from the abdomen (colon/splenic-flexure mobilization, IMA/IMV ligation, mobilization of the upper half of the rectum) while the other works transanally, starting with a circumferential full-thickness rectal transection in the intersphincteric plane and proceeding cephalad ("down-to-up" dissection, via what is essentially transanal single-port laparoscopy) until the two teams' dissection planes meet and the fully mobilized rectum is delivered through the transanal site for transection and anastomosis (handsewn or stapled low colorectal/coloanal, typically with diverting loop ileostomy). Proponents argue taTME allows a better distal margin and greater lymph node harvest, but a meta-analysis of 11 studies (757 patients) found no difference in cancer-/pathology-related outcomes or short-term complications compared with traditional laparoscopic LAR. Results from the International taTME registry indicate more intraoperative adverse events than would be expected for this type of procedure, many involving serious complications such as bleeding or urethral transection. taTME has a fairly steep learning curve, and further data are needed before its true utility and transferability can be fully evaluated — resolving this page's previous open item: primary outcome data now exist (registry safety signal + meta-analysis parity), even though a large head-to-head RCT is still lacking. See Surgical Ethics (Conflict of Interest, Innovation & End-of-Life Care) for taTME's use as a cautionary case study in the ethics-of-surgical-innovation literature — the Norway moratorium and Netherlands locoregional-recurrence reports it cites are the same registry-era safety signal summarized here, framed there as a lesson about rapid adoption after minimal training.

Additional safety detail and terminology, per ASCRS Ch36 - Colorectal Cancer Minimally Invasive Surgery: taTME (proposed 2010) is built on transabdominal-transanal proctosigmoidectomy (TATA), TEM, TAMIS, NOSE, and NOTES techniques. Claimed advantages beyond those above: longer distal resection margin (direct visual control of transection). Beyond the registry's bleeding/urethral-transection signal already noted, Ch36 adds CO2 embolism as a specifically reported complication, and a controversial concern about multifocal local recurrence potentially related to pneumoinsufflation and cancer cell spread (very rarely previously reported with other approaches) — however, a recent six-center study focused specifically on local recurrence after taTME found a reassuring 2-year LR rate of 3% with no multifocal recurrence pattern, suggesting good locoregional control is achievable with standardized technique. The ongoing COLOR III multicenter RCT should better define taTME's relative short- and long-term oncologic outcomes vs. laparoscopic TME — the large head-to-head RCT this page's prior open item noted as still lacking.

Detailed technique, per Ch36: abdominal steps (left colon/splenic flexure mobilization, IMA/IMV division, proximal mesorectal mobilization) can be performed before, after, or synchronous with transanal mobilization. Transanal setup: lithotomy/Trendelenburg positioning, pudendal block, self-retaining retractor to visualize the dentate line, transanal platform placement, and a purse-string suture whose distance from the anal verge/tumor depends on tumor-to-anorectal-junction (ARJ) distance — 3cm from the anal verge if the tumor is >4cm from the ARJ, 1cm distal to the tumor if 2-4cm from the ARJ, or dissection started without the platform first if <2cm from the ARJ. A rectal washout is typically performed after the purse-string is tied (rationale: reduce fecal contamination and possibly tumor cell implantation, though no data confirm this). After 360° full-thickness rectal wall incision, circumferential mesorectal dissection follows — posteriorly first (the avascular presacral space is the safest starting point), then anteriorly (rectovaginal septum in women, rectoprostatic plane in men, taking care to avoid urethral/prostate injury), with the neurovascular bundle at 2 and 10 o'clock flagged as a lateral danger zone. Air leak testing (standard via proctoscopy, or reverse via peritoneal insufflation) and ICG-FA perfusion checks are performed after anastomosis; proximal fecal diversion (loop ileostomy/colostomy) typically follows.

Multivisceral or extended resections

Per ASCRS Ch29 - Proctectomy for Rectal Cancer: approximately 10% of primary rectal cancers invade other organs/structures — these are staged as T4b. Multivisceral resection considerations depend on direction of invasion: anteriorly, the vagina, uterus, prostate, seminal vesicles, and bladder may be involved by direct extension; laterally, the ureters and iliac vessels may be involved in upper rectal cancers, with anything more laterally involved/within the pelvic sidewall generally deemed unresectable; posteriorly, the coccyx or sacrum may be involved. A single-institution series of 61 patients with locally advanced rectal cancer found multivisceral resection most often involved urogenital structures anteriorly (bladder, prostate, uterus, ovaries, vagina) — unsurprising, since tissue anterior to the rectum is soft viscera, while posterolaterally there is bone and pelvic sidewall.

In women, uterus/cervix/vagina involvement can typically be managed by en bloc resection of those organs (usually including ovaries and fallopian tubes); depending on the amount of vagina resected, primary closure vs. plastic surgical flap reconstruction may be needed for the residual defect. In men, anterior extension is more technically challenging — en bloc resection of the seminal vesicles/prostate is possible but more complex than the female-organ equivalent, with a greater likelihood of achieving R0 resection if pelvic exenteration (proctectomy with en bloc cystoprostatectomy and urinary conduit) is performed; a colonic conduit is usually more straightforward to construct than an ileal conduit if exenteration is performed, and avoids an additional intestinal anastomosis. This is exenteration for advanced primary rectal cancer — see Pelvic Exenteration for Locally Recurrent Rectal Cancer for the related but technically distinct scenario of exenteration for recurrent disease (which develops in extra-mesorectal planes and carries its own anatomic-compartment classification, technique, and outcomes data). Isolated distal ureteral involvement can be managed by en bloc resection with primary ureteral reimplantation. Posterior extension into the bony pelvis requires more extensive preoperative planning; en bloc coccygectomy is relatively straightforward, but sacrectomy is far more complex, requiring multispecialty planning with orthopedic oncology and/or neurosurgery. Lateral sidewall involvement is the most difficult and often does not permit an R0 resection — intraoperative radiation therapy should be considered in these cases if an attempt at resectable disease is made.

Locally advanced rectal cancers invading other structures (T4b) are sometimes described as "primary rectal cancer beyond TME planes" (PRCbTME) and require surgery outside the standard mesorectal ("holy") plane — planes for "extended resections" (outside the mesorectal plane, lateral to the ureters, and the deeper plane exposing the iliac vessels/lateral pelvic lymph nodes) are less familiar to most colorectal surgeons than the standard mesorectal plane, and are important to understand for a safe, properly performed en bloc resection. If any of these structures are involved/invaded at initial diagnosis (confirmed by MRI), strong consideration should be given to some form of neoadjuvant therapy to improve resectability and R0-resection likelihood — achieving R0 resection is paramount to long-term disease-free survival. A systematic review of multivisceral resections reported 5-year overall survival of 53% for primary locally advanced rectal cancer, notably higher than the 20% reported for multivisceral resection of recurrent rectal cancer. Neoadjuvant chemoradiation with long-course radiation (5400cGy with IV 5-FU or oral capecitabine) allows for tumor regression, higher R0-resection rates, downstaging of borderline-resectable tumors, and possibly improved overall outcomes — regardless of which tumor-regression-grading (TRG) system is used, there's a positive correlation between TRG and outcomes like local recurrence. Total neoadjuvant therapy (TNT) — delivering all adjuvant therapy before surgery (see Total Neoadjuvant Therapy (TNT)) — is gaining popularity and may be considered for any patient with locally advanced primary rectal cancer, given better tolerability and higher chemotherapy completion rates than a standard split regimen. Multidisciplinary tumor board presentation is essential for these patients, with review across medical oncology, radiation oncology, radiology, pathology, urology, gynecology, orthopedics/neurosurgery, and plastic surgery as needed.

Oncologic outcomes

Per ASCRS Ch29 - Proctectomy for Rectal Cancer: four decades ago, rectal cancer portended an abysmal course, with recurrence rates as high as 30% and poor functional outcomes; with the modern routine use of chemoradiation, TME technique, and multidisciplinary evaluation, worldwide local recurrence is now estimated between 4% and 8%. An SEER-database analysis of 372,130 patients comparing survival of locally advanced rectal vs. colon cancer patients found that, stage for stage, survival of locally advanced rectal cancer patients was equivalent to (if not superior to) colon cancer patients.

Surgical approach has increasingly skewed toward minimally invasive technique over the past decade. Two large RCTs — ACOSOG Z6051 (US) and the ALaCaRT trial (Australia/New Zealand) — failed to demonstrate noninferiority of the laparoscopic approach using a composite successful-resection measure (negative radial margin, negative distal margin, and complete/nearly-complete mesorectal grade — all individually shown to have prognostic significance in other trials). It's reassuring, however, that despite concerns about laparoscopic mesorectal-dissection quality, there have been no demonstrable survival differences: review of non-randomized National Cancer Database data (18,765 patients) demonstrated equivalence of minimally invasive and open approaches, and long-term survival outcomes from ACOSOG Z6051, ALaCaRT, and the NCDB have all since demonstrated equivalence between the two techniques.

Corroborating trial detail, per ASCRS Ch36 - Colorectal Cancer Minimally Invasive Surgery: the CLASICC trial found a 12% CRM-involvement rate after laparoscopic restorative proctectomy vs. 6% in the open arm, and a 34% conversion rate — its 5-year follow-up nonetheless showed no OS/DFS differences, matching the reassuring long-term pattern above. The COREAN trial showed short-term benefits (blood loss, pain, length of stay) and comparable 3-year DFS for laparoscopic vs. open proctectomy after neoadjuvant chemoradiation in non-metastatic mid-low rectal cancer. Both trials corroborate this section's existing ACOSOG-Z6051/ALaCaRT-based conclusion with matching CRM/conversion figures rather than extending it — still not independently ingested from primary literature.

Multidisciplinary rectal cancer care

Per ASCRS Ch29 - Proctectomy for Rectal Cancer: regionalization of rectal cancer care in Europe and Asia has produced national programs with data-driven approaches; the US lacks an equivalent regionalized system. The OSTRICH consortium queried the National Cancer Database to assess US variation in appropriate chemoradiotherapy delivery for locally advanced rectal cancer, finding adherence highest at high-volume centers vs. community centers (78% vs. 69%, OR 1.46, p<0.001) — the same group found a 17.2% rate of circumferential margin positivity in the US, roughly double the rate reported in Europe. The Commission on Cancer's National Accreditation Program for Rectal Cancer (NAPRC) aims to address these issues by creating uniformity in process measures related to rectal cancer care, such as mandatory MRI staging of all new rectal cancers and mandatory multispecialty tumor board discussion of all newly diagnosed rectal tumors. See Surgical Quality Measurement & Improvement for NAPRC's full accreditation structure (22 standards, its OSTRiCh origin, and verified-hospital counts as of 2020) and the broader quality-measurement framework it sits within.

Open items / gaps

  • No detail on nerve-sparing technique specifics beyond "must be visualized" for the hypogastric nerves and the general anatomy described above.
  • Functional outcome comparisons between standard mucosectomy, asymmetric mucosectomy, and intersphincteric dissection are qualitative here ("poor" for intersphincteric) rather than backed by specific data.
  • ACOSOG Z6051, ALaCaRT, CLASICC, COREAN, ROLARR, the SEER 372,130-patient analysis, and the OSTRICH/NCDB data are not independently ingested from primary publications — textbook-secondary- source-level per ASCRS Ch29 - Proctectomy for Rectal Cancer and ASCRS Ch36 - Colorectal Cancer Minimally Invasive Surgery.
  • The IntAct RCT (ICG-FA vs. standard perfusion assessment for anastomotic-leak prevention) has not yet reported results per Ch36 — worth revisiting once published; see also Anastomotic Construction's PILLAR-II-based ICG-FA content.
  • COLOR III (taTME vs. laparoscopic TME RCT) is ongoing, not yet reported.
  • No primary literature yet on the multivisceral-resection survival figures (53% vs. 20% for primary vs. recurrent disease) or the PRCbTME extended-resection-plane concept.